To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis
Clinical trial NCT05607446 · TERMINATED
Trial details
- NCT number
- NCT05607446
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-14
- Primary completion
- 2023-05-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.